Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Coldstream Wins NCI Contract | Contract Pharma

What are you searching for?

Sign in
Breaking News

Coldstream Wins NCI Contract

To develop and produce parenteral dosage forms of cancer drugs

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Coldstream Laboratories, Inc. has been awarded a five-year contract with the National Cancer Institute (NCI) for the program, “Development and Production of Parenteral Dosage Forms for Clinical Studies.” The program’s goal is to develop and produce parenteral dosage forms of cancer drugs for human use. Certain lead agents selected by the NCI will be assigned for development and production as parenteral products.
 
“The requirements for this program mesh perfectly with Coldstream’s capabilities and facilities. We couldn’t be more pleased to be awarded this opportunity to work with the NCI,” said Eric W. Smart, Coldstream’s president and chief executive officer. “We work hard to ensure the highest degree of quality in everything we do and being awarded this contract indicates that we are succeeding. Being awarded this contract affords Coldstream the opportunity to continue to make an impact in the field of cancer research and help advance oncologic care for the millions of people impacted by cancer every year.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics